Viewing Study NCT02260505

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:30 AM
Ignite Modification Date: 2026-01-11 @ 6:43 PM
Study NCT ID: NCT02260505
Status: COMPLETED
Last Update Posted: 2024-01-05
First Post: 2014-07-30
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Efficiency of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST)
Sponsor: Centre Leon Berard
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Gastrointestinal Stromal Tumors View
None Resected Gastrointestinal Stromal Tumors View
None Non-metastatic View
None High Risk of Recurrence View
None KIT Gene Mutation View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Gastrointestinal Stromal Tumors View
None Non-metastatic View
None KIT + View
None Imatinib View
None Adjuvant treatment View
None High risk of recurrence View
None Tyrosine kinase inhibitor View
None Disease Free Survival View
None Overall survival View
None Time To Secondary Resistance View
None Safety profile View
None Quality of Life during treatment View